
Ultra-minimum incision personalized personalized intratumoral chemoimmunotherapy e fana ka mokhoa o lebisitsoeng ho kalafo ea mofets'e, e fokotsa ho hlasela ha o ntse o eketsa katleho ea kalafo. Mokhoa ona o mocha o kopanya ho nepahala ha opereishene e fokolang haholo ka matla a meriana ea motho ka mong le immunotherapy, e lebisang liphellong tse ntlafetseng tsa mokuli le litla-morao tse fokotsehileng. Ithute ho eketsehileng ka tsoelo-pele ena e kholo ea tlhokomelo ea kankere.
Hangata liopereishene tsa setso tsa mofets'e li kenyelletsa ho seha ho hoholo, ho lebisang ho nako e telele ea ho hlaphoheloa le maqeba a maholo. Opereishene ea Ultra-minimum incision e sebelisa lisebelisoa le mekhoa ea ho buoa e tsoetseng pele ho etsa opereishene ka likarolo tse nyane haholo. Sena se fokotsa ho sithabela ha lisele, se baka bohloko bo fokolang, pholiso e potlakileng, le liphello tse ntlafetseng tsa litlolo. Sebopeho se nepahetseng sa mekhoa ena se lumella lingaka tse buoang hore li lebise hlahala hantle ha li ntse li boloka lisele tse phetseng hantle tse haufi le eona.
Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy e hlokomela litšobotsi tse ikhethang tsa lefutso le limolek’hule tsa hlahala ea mokuli e mong le e mong. Ka ho sekaseka litšoaneleho tsena, litsebi tsa oncologists li ka theha moralo oa kalafo oa motho ka mong o shebaneng le lisele tse itseng tsa mofetše ha li ntse li boloka lisele tse phetseng hantle. Mokhoa ona oa motho ka mong o eketsa katleho ea phekolo le ho fokotsa kotsi ea litla-morao tse kotsi ha li bapisoa le mekhoa e tloaelehileng, e lekanang-tsohle.
Tsamaiso ea chemotherapy le immunotherapy ka ho toba ka har'a hlahala (intratumoral delivery) e tiisa hore meriana e phahameng ka ho fetisisa e fihla ho sepheo, e leng ho eketsang katleho ea eona. Mokhoa ona o lebisitsoeng o fokotsa ho pepeseha ha tsamaiso ea lithethefatsi, ho fokotsa monyetla oa liphello tse mpe 'meleng oohle. Mekhoa e fapaneng ea ho pepa e ka sebelisoa ho latela mofuta o itseng oa mofetše le sebaka sa hlahala. Lipatlisiso li ntse li tsoela pele lefapheng lena, ho hlahloba mekhoa e mecha le e sebetsang haholoanyane ea ho fana ka lithethefatsi ka intratumoral.
Leano lena la kalafo le kopanya litlamorao tsa cytotoxic tsa chemotherapy le matla a matla a ho itšireletsa mafung a immunotherapy. Chemotherapy e bolaea lisele tsa mofetše ka ho toba, athe immunotherapy e thusa sesole sa 'mele ho lemoha le ho senya lisele tsa mofetše ka katleho. Motsoako oa liphekolo tsena tse peli tse matla li baka phello ea synergistic, hangata e lebisang ho ntlafatso ea litekanyetso tsa karabelo le tšoarelo ea nako e telele.
Melemo ea Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy kenyeletsa:
Lithuto tse ngata tsa lipatlisiso le liteko tsa bongaka li ntse li tsoela pele ho batlisisa ka katleho le polokeho ea Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ka mefuta e fapaneng ea mofetše. Lithuto tsena li fana ka leseli la bohlokoa mabapi le maano a nepahetseng a kalafo le mekhoa ea khetho ea bakuli. Bakeng sa liphetho tsa morao-rao tsa liphuputso, ho khothaletsoa ho sheba likoranta tsa bongaka tse hlahlobiloeng ke lithaka le mekhatlo e tsebahalang ea lipatlisiso tsa mofetše. The Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa o kentse letsoho ka mafolofolo liphuputsong tsena tse ntseng li tsoela pele.
Ha ke ntse ke tšepisa, Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ha e na mathata a ka hlahang. Tsena li kenyelletsa tlhokahalo ea tsebo le lisebelisoa tse khethehileng tsa ho buoa, ho rarahana ha moralo oa phekolo ea motho ka mong, le monyetla oa mathata a sa lebelloang. Lipatlisiso tse ling li bohlokoa ho rarolla mathata ana le ho holisa ts'ebeliso ea mokhoa ona o mocha oa kalafo. The Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa e ikemiselitse ho ntšetsa pele tsebo le tšebeliso ea phekolo ena.
ka thoko>
'mele>